Organogenesis Holdings Inc. 8-K

What Happened

• On May 7, 2026, Organogenesis Holdings Inc. (ORGO) announced its financial results for the fiscal first quarter ended March 31, 2026 via a press release. The company furnished that press release to the SEC as Exhibit 99.1 in an Item 2.02 Form 8‑K disclosure. The filing notes the press release is furnished (not filed) and therefore not subject to Section 18 liability or automatically incorporated by reference into other filings.

Key Details

• Announcement date: May 7, 2026.
• Reporting period: Fiscal quarter ended March 31, 2026 (Q1 2026).
• Exhibit: Press release furnished as Exhibit 99.1 (Cover Page Interactive XBRL included as Exhibit 104).
• Legal note: Information in the press release is furnished and not deemed “filed” under the Exchange Act.

Why It Matters

• This 8‑K signals Organogenesis has released its quarterly earnings/financial results; those results (revenue, net income/loss, margins, cash position, and any guidance) will be in the press release and are material for investors assessing the company’s performance. Because the release is furnished rather than filed, investors should review the press release itself and the company’s subsequent SEC filings (such as the Form 10‑Q) for the full, detailed financial statements and management discussion.